111, Inc. (NASDAQ: YI) (“111" or the “Company”), a leading integrated online and offline healthcare platform, announced that on July 5, 2019 it extended its strategic partnership with Eli Lilly and Company (NYSE: LLY) (“Lilly”), a global healthcare leader, by becoming a key distributor for the latter’s market-leading product “Cialis.”
July 11, 2019
· 3 min read